NCT00458094 Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses Status COMPLETED Phase NA
NCT00456430 Serotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant Response Status COMPLETED Phase PHASE4
NCT00456014 Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant Treatment Status COMPLETED Phase NA
NCT00449007 Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism Status TERMINATED Phase PHASE4
NCT00446719 Safety and Antidepressant Effects of Rellidep in Major Depressive Disorder Status COMPLETED Phase PHASE2/PHASE3
NCT00446407 Evaluating the Benefits and Affordability of a Program to Improve the Care of Common Mental Disorders in Primary Care Status COMPLETED Phase NA
NCT00442429 Morbidity and Mortality Among Dialysis Patients After Treatment for Depression Status UNKNOWN Phase N/A
NCT00441636 Treatment Resistant Depression and Obstructive Sleep Apnea, Effect of Continuous Positive Airway Pressure (CPAP) Status UNKNOWN Phase NA
NCT00439452 Telemedicine-Based Collaborative Care to Reduce Rural Disparities Status COMPLETED Phase NA
NCT00437385 Evaluation of Three Continuation Therapies After ECT Concerning Efficacy and Cognition in Severly Depressed Patients Status COMPLETED Phase PHASE1
NCT00436150 Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent Mothers Status COMPLETED Phase NA
NCT00429169 Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression Status TERMINATED Phase PHASE4
NCT00426946 Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study Status UNKNOWN Phase PHASE4
NCT00424203 Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery Status COMPLETED Phase PHASE2
NCT00423969 Galantamine Augmentation of Escitalopram for Treatment of Depression Status TERMINATED Phase PHASE4